Predictions
Royalty Pharma Plc
Start price
Target price
Perf. (%)
€36.00
15.12.20
15.12.20
€38.00
15.12.21
15.12.21
-6.11%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Rapt Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.90
15.12.20
15.12.20
€23.00
15.12.21
15.12.21
38.69%
16.12.21
16.12.21
Surge Copper Corp.
Start price
Target price
Perf. (%)
€0.39
15.12.20
15.12.20
€0.60
15.06.21
15.06.21
-30.84%
15.06.21
15.06.21
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.30
14.12.20
14.12.20
-
14.12.21
14.12.21
169.86%
07.07.21
07.07.21
Probably not worthwhile Investment
Biocardia Inc.
Start price
Target price
Perf. (%)
€4.53
14.12.20
14.12.20
-
-39.96%
30.12.20
30.12.20
Probably not worthwhile Investment
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.20
14.12.20
14.12.20
€11.00
14.12.21
14.12.21
15.85%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Biocardia Inc.
Start price
Target price
Perf. (%)
€4.53
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-24.50%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.90
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
158.23%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Synlogic Inc.
Start price
Target price
Perf. (%)
€3.00
14.12.20
14.12.20
€3.00
14.12.21
14.12.21
0.00%
29.01.21
29.01.21
Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
Navya S.a.
Start price
Target price
Perf. (%)
€3.86
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-42.05%
15.12.21
15.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Aim Immunotech Inc.
Start price
Target price
Perf. (%)
€1.51
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
-35.89%
15.12.21
15.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
CloudMD Software & Services Inc.
Start price
Target price
Perf. (%)
€1.39
14.12.20
14.12.20
€1.80
14.12.21
14.12.21
-40.43%
15.12.21
15.12.21
Hensoldt AG
Start price
Target price
Perf. (%)
€13.99
13.12.20
13.12.20
-
13.12.21
13.12.21
-11.94%
14.12.21
14.12.21
Leading role in innovation
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Goosehead Insurance Inc.
Start price
Target price
Perf. (%)
€95.00
13.12.20
13.12.20
€95.00
13.12.21
13.12.21
22.11%
14.12.21
14.12.21
Cambium Networks Corp.
Start price
Target price
Perf. (%)
€20.20
13.12.20
13.12.20
€22.00
13.12.21
13.12.21
0.00%
14.12.21
14.12.21
Mission Produce Inc.
Start price
Target price
Perf. (%)
€10.90
13.12.20
13.12.20
€13.00
13.12.21
13.12.21
45.87%
14.12.21
14.12.21
Niu Technologies
Start price
Target price
Perf. (%)
€24.60
13.12.20
13.12.20
€27.00
13.12.21
13.12.21
-36.42%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Maverix Metals Inc.
Start price
Target price
Perf. (%)
€4.06
13.12.20
13.12.20
€4.30
13.12.21
13.12.21
-10.84%
14.12.21
14.12.21
Ming Le Sports AG
Start price
Target price
Perf. (%)
€1.27
13.12.20
13.12.20
€1.00
13.12.21
13.12.21
77.95%
03.04.21
03.04.21
Top 10 in its market
Future proof or reliable business model
Good rating
High risks for its business
Up Fintech Holding Ltd.
Start price
Target price
Perf. (%)
€4.74
13.12.20
13.12.20
€28.00
23.10.24
23.10.24
-18.57%
06.01.22
06.01.22